Vertex has said on record that it has no plans ... has invested in an R&D site near Oxford and employs 250 people, of whom over 110 are scientists. But Leiden said that the UK must invest in ...

Vertex, which already has a research site in Oxford, hopes the tie-up will advance its efforts to develop transformation precision drugs for people with serious diseases. Using its analysis ...

executive vice president and chief scientific officer, Vertex Pharmaceuticals ... Department of Chemistry, University of Oxford, United Kingdom (Belgium) Hart, Sergiu; professor emeritus of ...

She reiterated her buy recommendation on Vertex stock, and kept her $583-per-share price target intact. According to reports, Merle's update was based on surveys with medical professionals ...

Vertex Pharmaceuticals misses analyst estimates on the top and bottom lines in the first quarter. Vertex raises its full-year 2025 revenue guidance to a range of $11.85 billion to $12 billion ...

Vertex Minerals chair Roger Jackson says he is confident the explorer is on the cusp of significant cash generation, as it moves toward production at its Hill End gold project in NSW. “This capital ...

Google updated the documentation for the Google-Extended user agent, which publishers can use to control whether Google Gemini and Vertex use their data for training purposes or for grounding AI ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated ...